Diversity in modern heart failure trials: Where are we, and where are we going

Over the last three decades, increased attention has been given to the representation of historically underrepresented groups within the landscape of pivotal clinical trials. However, recent events (i.e., coronavirus pandemic) have laid bare the potential continuation of historic inequities in avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Anaba, Uzoma, Ishola, Abiodun, Alabre, Alisha, Bui, Albert, Prince, Marloe, Okafor, Henry, Kola-Kehinde, Onaopepo, Joseph, Joshua J., Mitchell, Darrion, Odei, Bismarck C., Uzendu, Anezi, Williams, Karen Patricia, Capers, Quinn, Addison, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023064/
https://www.ncbi.nlm.nih.gov/pubmed/34920047
http://dx.doi.org/10.1016/j.ijcard.2021.12.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023064/
https://www.ncbi.nlm.nih.gov/pubmed/34920047
http://dx.doi.org/10.1016/j.ijcard.2021.12.018

Ejemplares similares